Publicaciones en colaboración con investigadoras/es de Hospital Universitario La Fe (19)

2024

  1. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?

    Cancers, Vol. 16, Núm. 7

2023

  1. Acclimation and Blood Sampling: Effects on Stress Markers in C57Bl/6J Mice

    Animals, Vol. 13, Núm. 18

  2. Prognostic factors in young women with epithelial ovarian cancer: the Young Ovarian Cancer-Care (YOC-Care) study

    International Journal of Gynecological Cancer

  3. Use of gonadotropins in ovarian stimulation in Spain: Delphi consensus

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, Vol. 43, Núm. 1, pp. 2174692

2021

  1. Congenital infection of SARS-CoV-2 in live-born neonates: a population-based descriptive study

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1521.e1-1521.e5

  2. One-step nucleic acid amplification (Osna) of sentinel lymph node in early-stage endometrial cancer: Spanish multicenter study (endo-osna)

    Cancers, Vol. 13, Núm. 17

  3. Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial

    American Journal of Obstetrics and Gynecology, Vol. 225, Núm. 3, pp. 308.e1-308.e14

2020

  1. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood, Vol. 135, Núm. 4, pp. 274-286

2018

  1. Correction to: SEOM clinical guidelines for endometrial cancer (2017) (Clinical and Translational Oncology, (2018), 20, 1, (29-37), 10.1007/s12094-017-1809-9)

    Clinical and Translational Oncology

  2. SEOM clinical guidelines for endometrial cancer (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 29-37

2010

  1. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

2008

  1. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients

    Journal of Medical Genetics, Vol. 45, Núm. 9, pp. 557-563

2007

  1. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: A negative outcome study by the Spanish breast cancer research group (GEICAM)

    Breast Cancer Research and Treatment, Vol. 101, Núm. 2, pp. 215-223

2005

  1. Association of Helicobacter pylori-related distal gastric cancer with the HLA II gene DQB1*0602 and cagA+ in a Southern European population

    Helicobacter, Vol. 10, Núm. 1, pp. 12-21

2003

  1. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: The IO-50 study, a prospective, observational, multicentre, open trial

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 110, Núm. 12, pp. 1072-1077

2002

  1. Criterios para la utilización de los recursos del Sistema Nacional de Salud Español en técnicas de reproducción humana asistida

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 19, Núm. 1, pp. 5

2001

  1. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: Evidence from a multicentre study in Spain

    Human Reproduction, Vol. 16, Núm. 12, pp. 2525-2532

1991

  1. Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the grupo ginecologico Español para el tratamiento oncologico (GGETO)

    European Journal of Cancer and Clinical Oncology, Vol. 27, Núm. 7, pp. 864-866

  2. Single agent epirubicin in squamous cell cervical cancer: A phase II trial

    Acta Oncologica, Vol. 30, Núm. 3, pp. 325-327